¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ

Dawn is now being deployed for use by scientists within ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ and across the UK to support ambitious goals in clean energy, personalised medicine and climate.

Every patient with cancer has a story to tell of their journey through diagnosis and treatment. We meet a group of women who are at the centre of pioneering research in ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ that’s changing the outcome of ovarian cancer – helping to create treatments that are as unique as their stories.

Researchers are working with pharmaceutical companies to make improvements across the whole supply chain, from how a pill is made to the moment it is swallowed by the patient.

How will precision medicine define 21st-century therapeutics? What will future healthcare look like? And what actually lies ‘beyond the pill’? Professor Chris Lowe, inaugural Director of the ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ Academy of Therapeutic Sciences, takes the long view on the future of therapeutics.

Dr Jag Srai, Head of the Centre for International Manufacturing at ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ's Institute for Manufacturing, and colleagues are developing new ways to help companies embrace the challenges and opportunities of digitalising the extended supply chain. Here, he provides a glimpse of this digital future.

Much hyped by the media, stem cells have tremendous power to improve human health. As part of the ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ Stem Cell Initiative, Dr Ludovic Vallier’s research in the Anne McLaren Laboratory for Regenerative Medicine shows how stem cells can further our understanding of disease and help deliver much-needed new treatments.